サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1728150

関節痛注射市場- 世界の産業規模、シェア、動向、機会、予測、注射タイプ別、用途別、地域別、競合別、2020-2030年

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Injection, By Application, By Region & Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

関節痛注射市場- 世界の産業規模、シェア、動向、機会、予測、注射タイプ別、用途別、地域別、競合別、2020-2030年
出版日: 2025年05月16日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

関節痛注射の世界市場規模は2024年に46億6,000万米ドルとなり、2030年にはCAGR 7.02%で大きな市場ポテンシャルに達し、力強い成長が見込まれています。

この市場セグメントは、変形性関節症や関節リウマチなどの関節関連疾患の世界の発生率の上昇に対応しています。関節痛注射では、慢性的な関節痛や炎症を管理するために、手術に代わる低侵襲で効果的な治療法を提供しています。これらの治療には、副腎皮質ステロイド、ヒアルロン酸、多血小板血漿（PRP）、胎盤組織マトリックス注射などがあり、痛みの軽減、可動性の改善、関節機能全般の向上を目的としています。世界人口の高齢化と非外科的治療オプションに対する需要の増加が市場拡大を加速しています。

市場概要
予測期間 2026-2030
市場規模：2024年 46億6,000万米ドル
市場規模：2030年 69億5,000万米ドル
CAGR：2025年～2030年 7.02%
急成長セグメント ヒアルロン酸注入
最大市場 北米

市場促進要因

肥満率の上昇

主な市場課題

償還の問題

主要市場動向

生物製剤と再生療法の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の関節痛注射市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 注射の種類別（ステロイド関節注射、ヒアルロン酸注射、多血小板血漿（PRP）注射、胎盤組織マトリックス（PTM）注射、その他）
    • 用途別（肩・肘、膝・足首、脊椎関節、股関節、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ
    • 注射の種類別
    • 用途別
    • 地域別

第6章 北米の関節痛注射市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の関節痛注射市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン

第8章 アジア太平洋地域の関節痛注射市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国

第9章 南米の関節痛注射市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの関節痛注射市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Anika Therapeutics Inc
  • Bioventus LLC
  • Ferring Pharmaceuticals Inc
  • Sanofi SA
  • Pfizer Inc
  • Eli Lilly & Co
  • Flexion Therapeutics Inc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet Holdings, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 20639

The Global Joint Pain Injections Market was valued at USD 4.66 billion in 2024 and is expected to witness robust growth, reaching significant market potential by 2030 with a CAGR of 7.02%. This market segment caters to the rising global incidence of joint-related disorders such as osteoarthritis and rheumatoid arthritis. Joint pain injections offer a minimally invasive and effective alternative to surgery for managing chronic joint pain and inflammation. These treatments include corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and placental tissue matrix injections, all designed to reduce pain, improve mobility, and enhance overall joint function. The aging global population and increasing demand for non-surgical treatment options are accelerating market expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.66 Billion
Market Size 2030USD 6.95 Billion
CAGR 2025-20307.02%
Fastest Growing SegmentHyaluronic Acid Injections
Largest MarketNorth America

Key Market Drivers

Rising Obesity Rates

The growing prevalence of obesity is a key driver propelling the demand for joint pain injections worldwide. As obesity rates rise, so does the burden on weight-bearing joints, increasing the risk of joint disorders like osteoarthritis. According to the World Health Organization, the number of obese individuals has significantly increased over the past few decades, with over 650 million people classified as obese in 2016. Excess weight leads to greater stress on joints, resulting in chronic pain and inflammation that often necessitates medical intervention. Joint pain injections offer an effective solution for managing this discomfort and are increasingly sought after as part of long-term pain management strategies in obese populations.

Key Market Challenges

Reimbursement Issues

Reimbursement limitations pose a significant barrier to the widespread adoption of joint pain injections. In many healthcare systems, inadequate insurance coverage discourages patients from opting for injection-based therapies due to high out-of-pocket expenses. This is particularly true for newer or biologic-based treatments, which tend to be more expensive. As a result, despite clinical efficacy, limited reimbursement frameworks can hinder market growth by restricting patient access to advanced treatment options.

Key Market Trends

Advancements in Biologics and Regenerative Therapies

Technological progress in biologics and regenerative medicine is shaping a major trend in the joint pain injections market. Treatments such as platelet-rich plasma (PRP) and placental tissue matrix (PTM) injections are gaining attention for their ability to promote tissue repair and deliver extended relief from joint pain. These therapies utilize the patient's own biological components or donor-derived materials to regenerate damaged tissues, offering an innovative approach to joint restoration. Continued R&D in this area is expected to yield next-generation injectable solutions that offer superior outcomes and durability, further enhancing patient appeal and clinical adoption.

Key Market Players

  • Anika Therapeutics Inc
  • Bioventus LLC
  • Ferring Pharmaceuticals Inc
  • Sanofi SA
  • Pfizer Inc
  • Eli Lilly & Co
  • Flexion Therapeutics Inc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet Holdings, Inc.

Report Scope:

In this report, the Global Joint Pain Injections Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Joint Pain Injections Market, By Type of Injection:

  • Steroid Joint Injections
  • Hyaluronic Acid Injections
  • Platelet-rich Plasma (PRP) Injections
  • Placental Tissue Matrix (PTM) Injections
  • Others

Joint Pain Injections Market, By Application:

  • Shoulder & Elbow
  • Knee & Ankle
  • Spinal Joints
  • Hip Joint
  • Others

Joint Pain Injections Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Joint Pain Injections Market.

Available Customizations:

Global Joint Pain Injections market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Joint Pain Injections Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 5.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Type of Injection
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Joint Pain Injections Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 6.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Joint Pain Injections Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Injection
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Joint Pain Injections Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Injection
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Joint Pain Injections Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Injection
        • 6.3.3.2.2. By Application

7. Europe Joint Pain Injections Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 7.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Joint Pain Injections Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Injection
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Joint Pain Injections Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Injection
        • 7.3.2.2.2. By Application
    • 7.3.3. France Joint Pain Injections Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Injection
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Joint Pain Injections Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Injection
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Joint Pain Injections Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Injection
        • 7.3.5.2.2. By Application

8. Asia-Pacific Joint Pain Injections Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 8.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Joint Pain Injections Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Injection
        • 8.3.1.2.2. By Application
    • 8.3.2. Japan Joint Pain Injections Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Injection
        • 8.3.2.2.2. By Application
    • 8.3.3. India Joint Pain Injections Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Injection
        • 8.3.3.2.2. By Application
    • 8.3.4. Australia Joint Pain Injections Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Injection
        • 8.3.4.2.2. By Application
    • 8.3.5. South Korea Joint Pain Injections Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Injection
        • 8.3.5.2.2. By Application

9. South America Joint Pain Injections Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 9.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Joint Pain Injections Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Injection
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Joint Pain Injections Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Injection
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Joint Pain Injections Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Injection
        • 9.3.3.2.2. By Application

10. Middle East and Africa Joint Pain Injections Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 10.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Joint Pain Injections Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Injection
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Joint Pain Injections Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Injection
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Joint Pain Injections Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Injection
        • 10.3.3.2.2. By Application
    • 10.3.4. Kuwait Joint Pain Injections Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type of Injection
        • 10.3.4.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Anika Therapeutics Inc
  • 14.2. Bioventus LLC
  • 14.3. Ferring Pharmaceuticals Inc
  • 14.4. Sanofi SA
  • 14.5. Pfizer Inc
  • 14.6. Eli Lilly & Co
  • 14.7. Flexion Therapeutics Inc
  • 14.8. Teva Pharmaceutical Industries Ltd
  • 14.9. Zimmer Biomet Holdings, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer